COVID-19 | AEMPS will carry out remote inspections of Good Practice in Pharmacovigilance

por Asphalion

Due to the current situation originated by COVID-19, the Spanish Agency for Medicines and Health Products (A​EMPS) announced last week that in order to allow the normal activity of Marketing Authori...

Leer más

Updated version of the document 'EMA post-authorisation procedural advice for users of the centralised procedure'

por Asphalion

Last week, European Medicin​es Agency (EMA) updated the guidance document “European Medicines Agency post-authorisation procedural advice for users of the centralised proc​edure”.

Leer más

New regulation to ease the renewal of the designation of NBs and prevent shortages of MDs in the EU

por Asphalion

The European Commission (EC) has published a Commission Implementing Regulation to ease the renewal of the designation of notified bodies (NBs) and prevent shortages of medical devices (MDs) in the Eu...

Leer más

Commission Implementing Decision C(2020) 2532

por Asphalion

The European Commission (EC) has published a Commission Implementing Decision requesting a review (standardisation) of a set of existing standards, as well as new standards to be drafted, for support ...

Leer más

WEBINAR | MDR postponed: an opportunity that cannot be missed

por Asphalion

Our last webinar is available on Asphalion’s YouTube Ch​annel.

Leer más

Asphalion participated in the nTRACK 30 MM follow up e-meeting

por Asphalion

​Last week , our colleagues Marta R​ayo and Marta Mor​ales participated in the nTRACK 30 MM follow up meeting to discuss the project progress with all the partners.

Leer más

23rd ASGCT Annual Meeting

por Asphalion

ASPHALION is participating in the 23rd ASGCT herapy Annual Meeting organized by the American Society of Gene & Cell Therapy.

Leer más

AsphaTrainings Program | Webinars schedule for May

por Asphalion

Following with our AsphaTrainings Program, today we present the May schedule with all the webinars that we have to offer in May.

Leer más

Medical Devices | Guidance documents on clinical investigation and evaluation

por Asphalion

This week brings some good news for the medical devices (MD) manufacturers and notified bodies, as 4 ​different guidance documents on topics related to clinical investigation and evaluation have bee...

Leer más

NDMA | Ranitidine medicines

por Asphalion

In September 2019, the European Commission (EC) requested EMA to start a review of ranitidine medicines after tests showed that some of these products contained the impurity N-nitrosodimethylamine (ND...

Leer más

Asphalion is offering all its expertise in Regulatory Affairs

por Asphalion

Asphalion and its experts are committed to bring solutions and alternatives to society during this exceptional situation. That is why we are offering all our expertise in Regulatory Affairs by:

Leer más

AsphaTrainings Program | At Asphalion we preparing a spring full of online trainings in Regulatory Affairs

por Asphalion

Today we are very pleased to announce the launch of the AsphaTrainings Program. We think it is essential to keep our Regulatory Affairs community updated and trained during this time. As a response ...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

La exposición al frío y al calor duran...

El equipo de investigadores observó cambios en el...

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Diapositiva de Fotos